WO2004015416A3 - Methods for the identification of agents with anti-microbial action - Google Patents
Methods for the identification of agents with anti-microbial action Download PDFInfo
- Publication number
- WO2004015416A3 WO2004015416A3 PCT/EP2003/008145 EP0308145W WO2004015416A3 WO 2004015416 A3 WO2004015416 A3 WO 2004015416A3 EP 0308145 W EP0308145 W EP 0308145W WO 2004015416 A3 WO2004015416 A3 WO 2004015416A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agents
- identification
- methods
- microbial action
- eukaryotic cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003255282A AU2003255282A1 (en) | 2002-08-06 | 2003-07-24 | Methods for the identification of agents with anti-microbial action |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10235967.9 | 2002-08-06 | ||
DE2002135967 DE10235967B4 (en) | 2002-08-06 | 2002-08-06 | Method for identifying substances with antimicrobial activity |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004015416A2 WO2004015416A2 (en) | 2004-02-19 |
WO2004015416A3 true WO2004015416A3 (en) | 2004-05-06 |
Family
ID=30775043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/008145 WO2004015416A2 (en) | 2002-08-06 | 2003-07-24 | Methods for the identification of agents with anti-microbial action |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003255282A1 (en) |
DE (1) | DE10235967B4 (en) |
WO (1) | WO2004015416A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0822260D0 (en) * | 2008-12-05 | 2009-01-14 | Merten Christoph | Assay |
AR108175A1 (en) | 2016-04-06 | 2018-07-25 | Innovative Molecules Gmbh | TIAZOL ACETAMIDA ANTIVÍRICOS COMPOUNDS |
CA3077397A1 (en) | 2017-10-05 | 2019-04-11 | Innovative Molecules Gmbh | Enantiomers of substituted thiazoles as antiviral compounds |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366738A (en) * | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
US5369095A (en) * | 1990-02-14 | 1994-11-29 | Alcon Laboratories, Inc. | Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers |
US5501959A (en) * | 1989-01-17 | 1996-03-26 | Alamar Biosciences Laboratory, Inc. | Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents |
US6046021A (en) * | 1995-04-12 | 2000-04-04 | Biolog, Inc. | Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a multiwell testing device |
WO2001000209A1 (en) * | 1999-06-29 | 2001-01-04 | Smithkline Beecham Corporation | Methods of use of fluoroquinolone compounds against bacteria |
WO2001081920A2 (en) * | 2000-04-20 | 2001-11-01 | Biolog, Inc. | Comparative phenotype analysis for assessment of biologically active compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU740745B2 (en) * | 1997-12-11 | 2001-11-15 | Biochem Pharma Inc. | Antiviral compounds |
GB9908195D0 (en) * | 1999-04-09 | 1999-06-02 | Microbiological Res Authority | Treatment of intracellular infection |
-
2002
- 2002-08-06 DE DE2002135967 patent/DE10235967B4/en not_active Expired - Fee Related
-
2003
- 2003-07-24 AU AU2003255282A patent/AU2003255282A1/en not_active Abandoned
- 2003-07-24 WO PCT/EP2003/008145 patent/WO2004015416A2/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366738A (en) * | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
US5501959A (en) * | 1989-01-17 | 1996-03-26 | Alamar Biosciences Laboratory, Inc. | Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents |
US5369095A (en) * | 1990-02-14 | 1994-11-29 | Alcon Laboratories, Inc. | Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers |
US6046021A (en) * | 1995-04-12 | 2000-04-04 | Biolog, Inc. | Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a multiwell testing device |
WO2001000209A1 (en) * | 1999-06-29 | 2001-01-04 | Smithkline Beecham Corporation | Methods of use of fluoroquinolone compounds against bacteria |
WO2001081920A2 (en) * | 2000-04-20 | 2001-11-01 | Biolog, Inc. | Comparative phenotype analysis for assessment of biologically active compounds |
Non-Patent Citations (3)
Title |
---|
AUBEL DOMINIQUE ET AL: "Design of a novel mammalian screening system for the detection of bioavailable, non-cytotoxic streptogramin antibiotics", JOURNAL OF ANTIBIOTICS (TOKYO), vol. 54, no. 1, January 2001 (2001-01-01), pages 44 - 55, XP001160773, ISSN: 0021-8820 * |
FISCHER AB: "Gentamycin as a bacteriocidal antibiotic in tissue culture", MED. MICROBIOL. IMMUNOL. (BERL.), vol. 161, no. 1, 1975, pages 23 - 39, XP008027169 * |
SIMALA-GRANT J L ET AL: "Antibiotic susceptibility of attached and free-floating Helicobacter pylori.", THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. ENGLAND MAY 2001, vol. 47, no. 5, May 2001 (2001-05-01), pages 555 - 563, XP002268772, ISSN: 0305-7453 * |
Also Published As
Publication number | Publication date |
---|---|
DE10235967B4 (en) | 2005-09-08 |
WO2004015416A2 (en) | 2004-02-19 |
AU2003255282A1 (en) | 2004-02-25 |
DE10235967A1 (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004029219A3 (en) | Cell-based rna interference and related methods and compositions | |
WO2003008636A3 (en) | Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection | |
WO2006015209A3 (en) | Differentiation of stem cells | |
BR0307630A (en) | Ultraexpression of extremozyme genes in closely related pseudomonas and bacteria | |
WO2004011611A3 (en) | Taci antibodies and uses thereof | |
AU2003241311A1 (en) | Simple catalytic dna biosensors for ions based on color changes | |
WO2005020785A3 (en) | Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis | |
EP1687283A4 (en) | Method and composition useful for determining fk 506 | |
WO2003008622A3 (en) | Exponential nucleic acid amplification using nicking endonucleases | |
EP2266396A3 (en) | Modulation of stem cells using zinc finger proteins | |
WO2005123913A3 (en) | Reversibly modified thermostable enzyme compositions and methods of making and using the same | |
CA2408348A1 (en) | Mixed cell systems for the detection of viruses | |
MXPA01011182A (en) | Methods, compositions and kits for biological indicator of sterilization. | |
ATE322550T1 (en) | METHOD FOR DETERMINING THE PRESENCE OF BACTERIA RESISTANT TO CELL-LYSING ANTIBIOTICS | |
EP1319402A4 (en) | Ige production inhibitors | |
WO2002065091A3 (en) | Pin1 as marker for abnormal cell growth | |
WO2005072290A3 (en) | Methods of treating, reducing, or preventing autoimmune conditions | |
AU2001279913A1 (en) | Method for cellular lysis of prokaryotes and eukaryotes or simultaneous cellularlysis or prokaryotes and eukaryotes | |
WO2004015416A3 (en) | Methods for the identification of agents with anti-microbial action | |
WO2005028680A3 (en) | Methods, compositions, and kits for the concentration and detection of microorganisms | |
WO2003035889A3 (en) | Compositions and methods for bacteria detection | |
TR199700796T1 (en) | Controlling post-harvest fungal diseases with the use of saprophytic yeast. | |
EP1506785A4 (en) | Composition for treating or preventing hyperuricemia | |
WO2003006497A3 (en) | Mutated photoproteins and their uses | |
WO2004009843A3 (en) | Detection of microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |